Latest Takeover Disputes News

The Takeovers Panel has directed Emu NL and its former directors to cover a combined $41,712 in costs incurred by Wayburn Holdings during takeover proceedings, underscoring ongoing regulatory scrutiny.

The Takeovers Panel has declared unacceptable circumstances in the Mayne Pharma acquisition, ordering Cosette Pharmaceuticals to comply with conditions preventing closure of the Salisbury manufacturing site. This ruling highlights concerns over market transparency and the integrity of the takeover process.

The Takeovers Panel has declined to review its earlier ruling on Keybridge Capital Limited, affirming no unacceptable circumstances exist. This decision closes a regulatory chapter but leaves some questions about future governance.

The Takeovers Panel has decided not to declare unacceptable circumstances following Keybridge Capital's challenge to Yowie Group's off-market takeover bid, which has now been withdrawn.

A fresh review application has been lodged against the Takeovers Panel's earlier decision involving Keybridge Capital Limited, signaling ongoing regulatory scrutiny.

The Takeovers Panel has decided not to proceed with an application challenging Keybridge Capital’s board decisions amid Yowie Group’s takeover bid, citing prior rulings and no unacceptable circumstances.

The Takeovers Panel has issued interim orders preventing Yowie Group Ltd from processing acceptances or declaring unconditional its takeover bid for Keybridge Capital Limited, maintaining the status quo amid ongoing proceedings.

Kinterra Capital has applied to the Takeovers Panel to halt New World Resources’ $10 million placement, arguing it could block rival bids amid an ongoing takeover dispute.